THE POSSIBLITY OF TRANQUILITY
MAY BE WITHIN REACH

Over the last half century, optimistic predictions of revolutionary advances in the treatment of brain disorders like schizophrenia have largely failed to materialize. The crude reality is, most people who suffer from schizophrenia and other major mental illnesses like depression, obsessive compulsive disorder, attention deficit hyperactivity disorder, autism and dementia are still left with debilitating social and functional deficits. SyneuRx is investigating novel therapies for these unmet medical needs. When successfully developed with the research trials, SyneuRx’ investigational therapy will provide those with mental disorders different treatment options.